ADM’s support solutions for GLP-1 users leverage our market insights, extensive ingredient pantry and full-formula product development capabilities. We’ll help you address the demand for tailored nutrition support for consumers currently engaging with GLP-1s, as well as those discontinuing the medications.
According to our proprietary research, 83% of US consumers taking GLP-1s find food products to be appealing when they are specifically marketed as supportive of people on GLP-1 medications.¹ Since starting GLP-1 treatments, many of these consumers have intentionally increased their intake of plant-based protein (41%), fiber (49%) and probiotics or prebiotics (39%).¹
To target the specific needs of GLP-1 users, we use functional and plant-based ingredients including biotics, botanical extracts, sweetening solutions, resistant tapioca starch, digestive support flour, naturally derived flavors and colors, and more. Our solutions focus on five needs during and after GLP-1 usage:
During GLP-1 Use
Muscle health – 20–40% of typical weight loss comes from muscle mass.² ADM’s plant-based proteins and wholesome ingredients can help solve this concern by supporting lean muscle mass.
GI comfort – 40% of consumers taking GLP-1s report GI discomfort.¹ Our products feature prebiotic dietary fiber and probiotics with clinically documented results for supporting digestive health.³ ⁴
Hydration – ADM research finds 44% of consumers taking GLP-1 products often feel less hydrated.¹ We can help make beverages more appealing with our sweetening solutions and flavor modulation technology.
When Discontinuing or Reducing GLP-1 Use
Satiety – GLP-1s reduce “food noise,” which may return when discontinuing treatment, putting increased importance on dietary levers to promote satiety.⁵ ADM delivers dietary prebiotic fiber that may increase satiety perception,⁶ along with resistant tapioca starch and plant-based ingredients used in satiating concepts.
Weight regain management – To help consumers with this part of their weight management journey, tap into our biotics targeting aspects of metabolic health,⁷ sweetening solutions, carb-conscious ingredients and high-protein options.
Learn more about ADM’s new platform and range of GLP-1 complementary nutrition solution concepts here.
References1. ADM Outside Voice™, Anti-Obesity Medications Survey, September 2024
2. Heymsfield, S. B.; et al. (2014) Obesity Reviews. 15(4): 310–21
3. Srivastava, S., et al (2024) Gut Microbes. 16(1)
4. Labellarte, G., et al. (2019) Food and Nutrition Sciences, 10, 626-634
5. Bettadapura S.; et al. (2024) International Journal of Obesity. 10.1038
6. Ye, Z.; et al. (2015). Nutritional Research, 35, 393-400
7. Pedret, A., et al. (2019) Int J Obes (Lond). 43(9):1863-1868
Please note that ADM products are not intended to treat, cure, or prevent any disease, nor are they designed to offer solutions for weight loss. This communication is intended for B2B use and no statements are meant to be perceived as approved by regulatory authorities. Local regulations must be reviewed to confirm permissibility of ingredients and claims for each food category.